• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Transition Therapeutics Inc. (TTHI)

    -NasdaqGM
    6.82 Down 0.03(0.44%) Dec 26, 3:48PM EST
    Add to Portfolio
    Prev Close:6.85
    Open:6.81
    Bid:6.82 x 1200
    Ask:6.88 x 100
    1y Target Est:10.25
    Beta:1.04
    Next Earnings Date:N/A
    Day's Range:6.81 - 6.82
    52wk Range:4.36 - 8.22
    Volume:1,017
    Avg Vol (3m):15,403
    Market Cap:240.24M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TTHI

    Comparison

    Symbol% ChgMkt Cap
    TTHIDown 0.44%240.24M
    GSKUp 0.70%103.73B
    MRKUp 0.56%164.72B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.84
    Quarterly EPS Est (Dec-14) :-0.23
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback